Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Riely
    Riely
  2. Kris
    Kris
  3. Ladanyi
    Ladanyi
  4. Rusch
    Rusch
  5. Drilon
    Drilon
  6. Arcila
    Arcila
  7. Yu
    Yu
  8. Bains
    Bains
  9. Chaft
    Chaft
  10. Paik
    Paik

Groups

  1. Department of Medicine (71)
  2. Solid Tumor Oncology Division (71)
  3. Thoracic Oncology (71)
  4. GSK Faculty (20)
  5. Human Oncology and Pathogenesis Program (19)
  6. Tow Center for Developmental Oncology (TCDO) (18)
  7. Surgery (17)
  8. Survivorship Research (11)
  9. Biostatistics Service (10)
  10. Epidemiology and Biostatistics (10)
Search Within
  1. "Solid Tumor Oncology Division"
  2. "Thoracic Oncology"
Formats
  1. Journal Article (53)
  2. Meeting Abstract (16)
  3. Editorial (2)
Groups
  1. Department of Medicine (71)
  2. Solid Tumor Oncology Division (71)
  3. Thoracic Oncology (71)
  4. GSK Faculty (20)
  5. Human Oncology and Pathogenesis Program (19)
  6. Tow Center for Developmental Oncology (TCDO) (18)

More Groups

People
  1. Gregory Riely (23)
  2. Marc Ladanyi (18)
  3. Mark Kris (18)
  4. Valerie Rusch (14)
  5. Alexander Drilon (12)
  6. Maria Arcila (8)

More People

Years
  1. 2024 (3)
  2. 2023 (5)
  3. 2022 (8)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (2)

More Years

Publications
  1. Lancet Oncology (29)
  2. Journal of Molecular Diagnostics (17)
  3. Annals of Thoracic Surgery (13)
  4. Value in Health (5)
  5. Lancet (3)
  6. Journal of Vascular and Interventional Radiology (2)

More Publications

Results (71)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): Primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
    Journal Article

    Smit, E. F.; Felip, E.; Uprety, D.; Nagasaka, M.; Nakagawa, K.; Paz-Ares Rodríguez, L.; Pacheco, J. M.; Li, B. T.; Planchard, D.; Baik, C.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Yttrium-90 transarterial radioembolization of primary lung cancer metastases to the liver
    Journal Article

    Alexander, E. S.; Petre, E. N.; Zhao, K.; Sotirchos, V.; Namakydoust, A.; Moussa, A.; Yuan, G.; Sofocleous, C. T.; Solomon, S. B.; Ziv, E.
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Patient characteristics, treatment patterns, and factors of biomarker testing among patients with advanced non-small cell lung cancer (ANSCLC) in the US, 2012-2020
    Meeting Abstract

    Yang, M.; MacEwan, J. P.; Honnold, R.; McClain, M. R.; O'Hara, R.; Liu, F.; Paik, P.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Health utility analysis of tepotinib in patients with non-small cell lung cancer harboring MET exon 14 skipping
    Journal Article

    Yang, M.; Vioix, H.; Hook, E. S.; Hatswell, A. J.; Batteson, R. L.; Gaumond, B. R.; O'Brate, A.; Popat, S.; Paik, P. K.
    Value in Health (2023)

    Fulltext@MSK | Save
  • COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease
    Journal Article

    Moey, M. Y. Y.; Hennessy, C.; French, B.; Warner, J. L.; Tucker, M. D.; Hausrath, D. J.; Shah, D. P.; DeCara, J. M.; Bakouny, Z.; Labaki, C.; more...
    Translational Oncology (2023)

    Fulltext@MSK | Save
  • Cost-effectiveness of tepotinib versus capmatinib for the treatment of adult patients with metastatic non–small cell lung cancer harboring mesenchymal–epithelial transition exon 14 skipping
    Journal Article

    Yang, M.; Vioix, H.; Sachdev, R.; Stargardter, M.; Tosh, J.; Pfeiffer, B. M.; Paik, P. K.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of percutaneous cryoablation for primary and metastatic intrathoracic, pleural based tumors
    Meeting Abstract

    Alexander, E.; Petre, N.; Offin, M.; Zauderer, M.; Zhao, K.; Sotirchos, V.; Ziv, E.; Solomon, S.
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison (MAIC) of tepotinib with capmatinib in previously treated advanced non-small cell lung cancer (aNSCLC) with met exon 14 (METex14) skipping
    Meeting Abstract

    Paik, P.; Pfeiffer, B.; Vioix, H.; Postma, M. J.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): A phase 1/2, open-label, basket trial
    Journal Article

    Subbiah, V.; Wolf, J.; Konda, B.; Kang, H.; Spira, A.; Weiss, J.; Takeda, M.; Ohe, Y.; Khan, S.; Ohashi, K.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save